

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.47949944 |
| 2 | respiratory burst (GO:0045730) | 5.80870554 |
| 3 | leukocyte aggregation (GO:0070486) | 5.80770212 |
| 4 | response to peptidoglycan (GO:0032494) | 5.65073791 |
| 5 | cellular extravasation (GO:0045123) | 5.35650617 |
| 6 | positive regulation of mast cell activation (GO:0033005) | 5.27658848 |
| 7 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 5.20006437 |
| 8 | positive regulation of mast cell degranulation (GO:0043306) | 5.20006437 |
| 9 | neutrophil activation (GO:0042119) | 5.14961647 |
| 10 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.07299244 |
| 11 | granulocyte activation (GO:0036230) | 4.94572699 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.87547751 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.87547751 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.87547751 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.87547751 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 4.87547751 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.87547751 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.74214765 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.71660680 |
| 20 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.46776507 |
| 21 | neutrophil mediated immunity (GO:0002446) | 4.36745383 |
| 22 | detection of external biotic stimulus (GO:0098581) | 4.36032809 |
| 23 | regulation of mast cell degranulation (GO:0043304) | 4.35631343 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.25621140 |
| 25 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.19249691 |
| 26 | regulation of mast cell activation (GO:0033003) | 4.18930796 |
| 27 | response to host immune response (GO:0052572) | 4.18088266 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.18088266 |
| 29 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.16165641 |
| 30 | superoxide anion generation (GO:0042554) | 4.13992487 |
| 31 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.09471509 |
| 32 | microglial cell activation (GO:0001774) | 4.09224644 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.04518480 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.04239286 |
| 35 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.01651935 |
| 36 | positive regulation of interferon-alpha production (GO:0032727) | 4.00182646 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 3.99465677 |
| 38 | regulation of leukocyte degranulation (GO:0043300) | 3.98274281 |
| 39 | reactive oxygen species biosynthetic process (GO:1903409) | 3.97799433 |
| 40 | positive regulation of leukocyte degranulation (GO:0043302) | 3.95107283 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.92060334 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.91772619 |
| 43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.89372652 |
| 44 | macrophage activation (GO:0042116) | 3.86693964 |
| 45 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.85632969 |
| 46 | detection of biotic stimulus (GO:0009595) | 3.85503011 |
| 47 | regulation of interferon-alpha production (GO:0032647) | 3.79297412 |
| 48 | macrophage activation involved in immune response (GO:0002281) | 3.79038175 |
| 49 | neutrophil chemotaxis (GO:0030593) | 3.77142858 |
| 50 | response to host (GO:0075136) | 3.75546215 |
| 51 | response to host defenses (GO:0052200) | 3.75546215 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.75546215 |
| 53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.67090238 |
| 54 | neutrophil migration (GO:1990266) | 3.66813667 |
| 55 | negative regulation of T cell mediated immunity (GO:0002710) | 3.64360263 |
| 56 | response to fungus (GO:0009620) | 3.61631560 |
| 57 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.57183559 |
| 58 | myeloid cell activation involved in immune response (GO:0002275) | 3.56436925 |
| 59 | positive regulation of antigen processing and presentation (GO:0002579) | 3.56003453 |
| 60 | response to muramyl dipeptide (GO:0032495) | 3.55664805 |
| 61 | leukocyte mediated cytotoxicity (GO:0001909) | 3.50675593 |
| 62 | B cell mediated immunity (GO:0019724) | 3.50212611 |
| 63 | eosinophil migration (GO:0072677) | 3.49877905 |
| 64 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.48592586 |
| 65 | negative regulation of cell killing (GO:0031342) | 3.48592586 |
| 66 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.48279268 |
| 67 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.48071968 |
| 68 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.44733930 |
| 69 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.43680210 |
| 70 | granulocyte migration (GO:0097530) | 3.42887900 |
| 71 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.42114089 |
| 72 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.41970963 |
| 73 | detection of other organism (GO:0098543) | 3.39888696 |
| 74 | response to interleukin-15 (GO:0070672) | 3.39188056 |
| 75 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.38896854 |
| 76 | negative regulation of mast cell activation (GO:0033004) | 3.36463017 |
| 77 | type I interferon signaling pathway (GO:0060337) | 3.35184389 |
| 78 | cellular response to type I interferon (GO:0071357) | 3.35184389 |
| 79 | response to type I interferon (GO:0034340) | 3.31897523 |
| 80 | granulocyte chemotaxis (GO:0071621) | 3.31854736 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 3.31712419 |
| 82 | myeloid leukocyte mediated immunity (GO:0002444) | 3.31107089 |
| 83 | germinal center formation (GO:0002467) | 3.30321550 |
| 84 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.30135907 |
| 85 | regulation of regulated secretory pathway (GO:1903305) | 3.27347717 |
| 86 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.26427860 |
| 87 | regulation of tolerance induction (GO:0002643) | 3.22299919 |
| 88 | T-helper 1 type immune response (GO:0042088) | 3.20933639 |
| 89 | defense response to protozoan (GO:0042832) | 3.17723817 |
| 90 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17519926 |
| 91 | negative regulation of interleukin-12 production (GO:0032695) | 3.17007524 |
| 92 | leukocyte cell-cell adhesion (GO:0007159) | 3.15354627 |
| 93 | phagosome maturation (GO:0090382) | 3.15320973 |
| 94 | response to protozoan (GO:0001562) | 3.14255240 |
| 95 | defense response to fungus (GO:0050832) | 3.14101929 |
| 96 | cellular response to interleukin-15 (GO:0071350) | 3.13693046 |
| 97 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.13346475 |
| 98 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.13178976 |
| 99 | leukocyte degranulation (GO:0043299) | 3.12918604 |
| 100 | regulation of monocyte chemotaxis (GO:0090025) | 3.10498018 |
| 101 | regulation of B cell differentiation (GO:0045577) | 3.09846231 |
| 102 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.08268520 |
| 103 | leukotriene metabolic process (GO:0006691) | 3.07857707 |
| 104 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.05844618 |
| 105 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.05568621 |
| 106 | cellular response to zinc ion (GO:0071294) | 3.04985407 |
| 107 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.03535150 |
| 108 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.01214743 |
| 109 | negative regulation of interleukin-6 production (GO:0032715) | 3.01023265 |
| 110 | myeloid dendritic cell differentiation (GO:0043011) | 3.00268705 |
| 111 | negative regulation of innate immune response (GO:0045824) | 2.99831256 |
| 112 | detection of bacterium (GO:0016045) | 2.99219360 |
| 113 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.99195130 |
| 114 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.99033437 |
| 115 | myeloid leukocyte activation (GO:0002274) | 2.98685709 |
| 116 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.97516454 |
| 117 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.97266464 |
| 118 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.97266464 |
| 119 | detection of molecule of bacterial origin (GO:0032490) | 2.96403816 |
| 120 | positive regulation of type 2 immune response (GO:0002830) | 2.96129616 |
| 121 | regulation of antigen processing and presentation (GO:0002577) | 2.94956623 |
| 122 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.94927996 |
| 123 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.94725620 |
| 124 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.94704749 |
| 125 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.94395323 |
| 126 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.93190945 |
| 127 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.93190945 |
| 128 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.91811440 |
| 129 | myeloid dendritic cell activation (GO:0001773) | 2.89917464 |
| 130 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.89772301 |
| 131 | negative regulation of interleukin-1 production (GO:0032692) | 2.89726339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.96736348 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.44714238 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.92747887 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.55269721 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.23733107 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.92314155 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.80095700 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.76870215 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.72913160 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.51289219 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.40879171 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.32398630 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.09837474 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.97371822 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.90440058 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.90418494 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.78298395 |
| 18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.63148650 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.58308210 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.55228015 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30975487 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.14861796 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.10138123 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02446260 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 1.92611014 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.91716946 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89250360 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.85056406 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.84001443 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.81483236 |
| 31 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.80874886 |
| 32 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.79147457 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.77927155 |
| 34 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.76745076 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.76473754 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.74998004 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70480890 |
| 38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70322345 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57956939 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.57909476 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.52071409 |
| 42 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.51603920 |
| 43 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50741037 |
| 44 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.50423595 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48996854 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47788868 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47757306 |
| 48 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.47624297 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.47474960 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36523148 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36098092 |
| 52 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35172851 |
| 53 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.31715973 |
| 54 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31650251 |
| 55 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31632849 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31181749 |
| 57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29409395 |
| 58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.28938680 |
| 59 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26308425 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25257723 |
| 61 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24350861 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23671996 |
| 63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23390502 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18658886 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14147524 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13019343 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.04489284 |
| 68 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03927070 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.03165978 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01828622 |
| 71 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.96495503 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95558701 |
| 73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94846895 |
| 74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.93307545 |
| 75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92048840 |
| 76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91954007 |
| 77 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89551320 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88002294 |
| 79 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.86900851 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86396892 |
| 81 | MYC_22102868_ChIP-Seq_BL_Human | 0.84762486 |
| 82 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84758598 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83627042 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83279379 |
| 85 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83264527 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82723913 |
| 87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82192865 |
| 88 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82068641 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81671210 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.80825517 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79011744 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.78536213 |
| 93 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78077926 |
| 94 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77455640 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76362385 |
| 96 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73286035 |
| 97 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.72352736 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69235125 |
| 99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69235125 |
| 100 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68895880 |
| 101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.68532177 |
| 102 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.67987128 |
| 103 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.67873397 |
| 104 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.67093974 |
| 105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.65053347 |
| 106 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.64744854 |
| 107 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.64336266 |
| 108 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.63553729 |
| 109 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.59894353 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.59242972 |
| 111 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.58974457 |
| 112 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.58974457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.98400708 |
| 2 | MP0009785_altered_susceptibility_to | 4.22855673 |
| 3 | MP0003303_peritoneal_inflammation | 4.21467682 |
| 4 | MP0001835_abnormal_antigen_presentation | 4.11842738 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.79615299 |
| 6 | MP0002419_abnormal_innate_immunity | 3.49274292 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.28887590 |
| 8 | MP0005025_abnormal_response_to | 3.17654646 |
| 9 | MP0000685_abnormal_immune_system | 2.90329343 |
| 10 | MP0003724_increased_susceptibility_to | 2.86030902 |
| 11 | MP0001790_abnormal_immune_system | 2.77672109 |
| 12 | MP0005387_immune_system_phenotype | 2.77672109 |
| 13 | MP0005671_abnormal_response_to | 2.68990554 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.63726328 |
| 15 | MP0009278_abnormal_bone_marrow | 2.61370295 |
| 16 | MP0001800_abnormal_humoral_immune | 2.58816276 |
| 17 | MP0002723_abnormal_immune_serum | 2.53089515 |
| 18 | MP0004510_myositis | 2.49276647 |
| 19 | MP0001533_abnormal_skeleton_physiology | 2.47663516 |
| 20 | MP0001853_heart_inflammation | 2.36335785 |
| 21 | MP0001819_abnormal_immune_cell | 2.33831493 |
| 22 | MP0006082_CNS_inflammation | 2.31036442 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.30531485 |
| 24 | MP0009764_decreased_sensitivity_to | 2.19188041 |
| 25 | MP0002405_respiratory_system_inflammati | 2.16349261 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.10633251 |
| 27 | MP0001845_abnormal_inflammatory_respons | 2.06960300 |
| 28 | MP0000343_altered_response_to | 2.05760967 |
| 29 | MP0005167_abnormal_blood-brain_barrier | 1.99753177 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.99502222 |
| 31 | MP0003075_altered_response_to | 1.93373759 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.74917449 |
| 33 | MP0008469_abnormal_protein_level | 1.73623989 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.70182767 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.70182767 |
| 36 | MP0004947_skin_inflammation | 1.69646875 |
| 37 | MP0000716_abnormal_immune_system | 1.66703950 |
| 38 | MP0003183_abnormal_peptide_metabolism | 1.64461188 |
| 39 | MP0003448_altered_tumor_morphology | 1.64102244 |
| 40 | MP0002398_abnormal_bone_marrow | 1.59651978 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.51420874 |
| 42 | MP0000858_altered_metastatic_potential | 1.44603564 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.43289605 |
| 44 | MP0005310_abnormal_salivary_gland | 1.41688430 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.38454414 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.36171584 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.34973616 |
| 48 | MP0002429_abnormal_blood_cell | 1.33405290 |
| 49 | MP0005166_decreased_susceptibility_to | 1.31458774 |
| 50 | MP0002933_joint_inflammation | 1.31090959 |
| 51 | MP0003828_pulmonary_edema | 1.30565709 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.28218212 |
| 53 | MP0004883_abnormal_blood_vessel | 1.27979210 |
| 54 | MP0002006_tumorigenesis | 1.25308255 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.23893633 |
| 56 | MP0009840_abnormal_foam_cell | 1.20797739 |
| 57 | MP0005164_abnormal_response_to | 1.18748670 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.16446310 |
| 59 | MP0002722_abnormal_immune_system | 1.15793447 |
| 60 | MP0005390_skeleton_phenotype | 1.15659037 |
| 61 | MP0001851_eye_inflammation | 1.15238276 |
| 62 | MP0008004_abnormal_stomach_pH | 1.14130685 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.11273701 |
| 64 | MP0009763_increased_sensitivity_to | 1.02874009 |
| 65 | MP0004381_abnormal_hair_follicle | 1.01914884 |
| 66 | MP0000604_amyloidosis | 0.99140651 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 0.96673561 |
| 68 | MP0002166_altered_tumor_susceptibility | 0.93322511 |
| 69 | MP0000569_abnormal_digit_pigmentation | 0.92899460 |
| 70 | MP0004782_abnormal_surfactant_physiolog | 0.90892166 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 0.89890969 |
| 72 | MP0000920_abnormal_myelination | 0.88757080 |
| 73 | MP0002837_dystrophic_cardiac_calcinosis | 0.86892528 |
| 74 | MP0005076_abnormal_cell_differentiation | 0.86824650 |
| 75 | MP0008260_abnormal_autophagy | 0.86719473 |
| 76 | MP0003690_abnormal_glial_cell | 0.84188093 |
| 77 | MP0002138_abnormal_hepatobiliary_system | 0.83086123 |
| 78 | MP0006054_spinal_hemorrhage | 0.81544091 |
| 79 | MP0001958_emphysema | 0.80562464 |
| 80 | MP0001986_abnormal_taste_sensitivity | 0.80333282 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.80067090 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 0.79377397 |
| 83 | MP0005451_abnormal_body_composition | 0.77686739 |
| 84 | MP0003186_abnormal_redox_activity | 0.77363447 |
| 85 | MP0003866_abnormal_defecation | 0.76621444 |
| 86 | MP0000249_abnormal_blood_vessel | 0.76141143 |
| 87 | MP0003279_aneurysm | 0.75050764 |
| 88 | MP0002254_reproductive_system_inflammat | 0.72060404 |
| 89 | MP0003795_abnormal_bone_structure | 0.72009914 |
| 90 | MP0003763_abnormal_thymus_physiology | 0.71249367 |
| 91 | MP0003045_fibrosis | 0.70531786 |
| 92 | MP0005075_abnormal_melanosome_morpholog | 0.70170968 |
| 93 | MP0003566_abnormal_cell_adhesion | 0.68593610 |
| 94 | MP0003705_abnormal_hypodermis_morpholog | 0.67464626 |
| 95 | MP0001663_abnormal_digestive_system | 0.67432361 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.65882695 |
| 97 | MP0002396_abnormal_hematopoietic_system | 0.65355152 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.64527999 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.63773734 |
| 100 | MP0008874_decreased_physiological_sensi | 0.63506972 |
| 101 | MP0002693_abnormal_pancreas_physiology | 0.61738078 |
| 102 | MP0005023_abnormal_wound_healing | 0.60076309 |
| 103 | MP0001873_stomach_inflammation | 0.59754211 |
| 104 | MP0010307_abnormal_tumor_latency | 0.57421499 |
| 105 | MP0002877_abnormal_melanocyte_morpholog | 0.55517675 |
| 106 | MP0000767_abnormal_smooth_muscle | 0.54732885 |
| 107 | MP0000703_abnormal_thymus_morphology | 0.53511095 |
| 108 | MP0002653_abnormal_ependyma_morphology | 0.52834619 |
| 109 | MP0005535_abnormal_body_temperature | 0.49107119 |
| 110 | MP0004130_abnormal_muscle_cell | 0.47647374 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.47635473 |
| 112 | MP0001542_abnormal_bone_strength | 0.47301969 |
| 113 | MP0000371_diluted_coat_color | 0.46212073 |
| 114 | MP0002132_abnormal_respiratory_system | 0.45047774 |
| 115 | MP0000015_abnormal_ear_pigmentation | 0.44746231 |
| 116 | MP0000490_abnormal_crypts_of | 0.44562548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 9.41212909 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 8.57233465 |
| 3 | Eczematoid dermatitis (HP:0000976) | 8.44568200 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.80925851 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.76796778 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 5.60302876 |
| 7 | Recurrent skin infections (HP:0001581) | 5.05751076 |
| 8 | Gingivitis (HP:0000230) | 4.93401054 |
| 9 | Obstructive lung disease (HP:0006536) | 4.84736354 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.84736354 |
| 11 | Stomatitis (HP:0010280) | 4.49326934 |
| 12 | Myositis (HP:0100614) | 4.46000098 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.32655526 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.25571333 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 4.02848145 |
| 16 | Cellulitis (HP:0100658) | 3.96295022 |
| 17 | Orchitis (HP:0100796) | 3.88530538 |
| 18 | Vacuolated lymphocytes (HP:0001922) | 3.73680272 |
| 19 | Urticaria (HP:0001025) | 3.68772280 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.60843596 |
| 21 | Optic neuritis (HP:0100653) | 3.60843596 |
| 22 | Interstitial pulmonary disease (HP:0006530) | 3.48983105 |
| 23 | Increased cerebral lipofuscin (HP:0011813) | 3.45392534 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.42022669 |
| 25 | Vasculitis (HP:0002633) | 3.35468237 |
| 26 | Meningitis (HP:0001287) | 3.24539483 |
| 27 | Episodic fever (HP:0001954) | 3.22505807 |
| 28 | Increased IgM level (HP:0003496) | 3.18407421 |
| 29 | Periodontitis (HP:0000704) | 3.17602838 |
| 30 | Hypochromic microcytic anemia (HP:0004840) | 3.13639292 |
| 31 | Spontaneous hematomas (HP:0007420) | 3.09618026 |
| 32 | Pustule (HP:0200039) | 3.08655280 |
| 33 | Recurrent pneumonia (HP:0006532) | 3.04905084 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 3.01253224 |
| 35 | Recurrent viral infections (HP:0004429) | 2.93455338 |
| 36 | Anorexia (HP:0002039) | 2.93219539 |
| 37 | Hematochezia (HP:0002573) | 2.91226049 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.90393187 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 2.90393187 |
| 40 | T lymphocytopenia (HP:0005403) | 2.87763714 |
| 41 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.85750307 |
| 42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.85750307 |
| 43 | Abnormality of glycolipid metabolism (HP:0010969) | 2.85750307 |
| 44 | Colitis (HP:0002583) | 2.82639276 |
| 45 | Petechiae (HP:0000967) | 2.80834614 |
| 46 | Hypochromic anemia (HP:0001931) | 2.80636545 |
| 47 | Abnormality of T cell number (HP:0011839) | 2.80098763 |
| 48 | Glomerulonephritis (HP:0000099) | 2.74140743 |
| 49 | Gingival bleeding (HP:0000225) | 2.73396286 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.68109692 |
| 51 | Basal ganglia calcification (HP:0002135) | 2.66892131 |
| 52 | Hypergammaglobulinemia (HP:0010702) | 2.66594873 |
| 53 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.66362166 |
| 54 | Gangrene (HP:0100758) | 2.62202788 |
| 55 | Osteomyelitis (HP:0002754) | 2.61400944 |
| 56 | Recurrent lower respiratory tract infections (HP:0002783) | 2.56852985 |
| 57 | Inflammation of the large intestine (HP:0002037) | 2.55909334 |
| 58 | Hepatosplenomegaly (HP:0001433) | 2.49118007 |
| 59 | Thick nail (HP:0001805) | 2.47803994 |
| 60 | Abnormality of the pleura (HP:0002103) | 2.44433662 |
| 61 | Leukocytosis (HP:0001974) | 2.44411622 |
| 62 | Increased serum ferritin (HP:0003281) | 2.40193742 |
| 63 | Disinhibition (HP:0000734) | 2.37681634 |
| 64 | Arterial thrombosis (HP:0004420) | 2.37022580 |
| 65 | Axonal loss (HP:0003447) | 2.36479670 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.36051897 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.35732494 |
| 68 | Abnormality of T cells (HP:0002843) | 2.35490592 |
| 69 | Peritonitis (HP:0002586) | 2.34146920 |
| 70 | Joint hemorrhage (HP:0005261) | 2.33678354 |
| 71 | Gastrointestinal infarctions (HP:0005244) | 2.29718732 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28386290 |
| 73 | Abnormality of iron homeostasis (HP:0011031) | 2.26684837 |
| 74 | Epistaxis (HP:0000421) | 2.25182680 |
| 75 | Hemoptysis (HP:0002105) | 2.24094294 |
| 76 | Sepsis (HP:0100806) | 2.22593388 |
| 77 | Increased IgE level (HP:0003212) | 2.22524568 |
| 78 | Granulocytopenia (HP:0001913) | 2.21969085 |
| 79 | Panhypogammaglobulinemia (HP:0003139) | 2.21076334 |
| 80 | Gastrointestinal stroma tumor (HP:0100723) | 2.20857542 |
| 81 | Polyneuropathy (HP:0001271) | 2.19271265 |
| 82 | Vertigo (HP:0002321) | 2.18763388 |
| 83 | Keratitis (HP:0000491) | 2.17788172 |
| 84 | IgM deficiency (HP:0002850) | 2.15721468 |
| 85 | Dysostosis multiplex (HP:0000943) | 2.14792801 |
| 86 | Chronic otitis media (HP:0000389) | 2.14031196 |
| 87 | Acne (HP:0001061) | 2.13863970 |
| 88 | Prostate neoplasm (HP:0100787) | 2.13503022 |
| 89 | Microcytic anemia (HP:0001935) | 2.13415198 |
| 90 | Abnormality of the endocardium (HP:0004306) | 2.12820445 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.11793514 |
| 92 | Osteolytic defects of the hand bones (HP:0009699) | 2.10386995 |
| 93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10386995 |
| 94 | Abnormality of the pericardium (HP:0001697) | 2.08326732 |
| 95 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07143221 |
| 96 | Myocardial infarction (HP:0001658) | 2.06822346 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03551737 |
| 98 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03551737 |
| 99 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03551737 |
| 100 | Amyloidosis (HP:0011034) | 2.02874543 |
| 101 | Skin ulcer (HP:0200042) | 2.02763585 |
| 102 | Purpura (HP:0000979) | 2.01965537 |
| 103 | Eosinophilia (HP:0001880) | 2.01639525 |
| 104 | Glomerulopathy (HP:0100820) | 2.01577324 |
| 105 | Mutism (HP:0002300) | 1.98557131 |
| 106 | Premature loss of primary teeth (HP:0006323) | 1.97559922 |
| 107 | Abnormality of the peritoneum (HP:0002585) | 1.97013221 |
| 108 | Nephritis (HP:0000123) | 1.94474574 |
| 109 | Abnormality of T cell physiology (HP:0011840) | 1.93972592 |
| 110 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92129157 |
| 111 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.90582059 |
| 112 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.90230227 |
| 113 | Lymphopenia (HP:0001888) | 1.90033759 |
| 114 | Pulmonary embolism (HP:0002204) | 1.89935464 |
| 115 | Prolonged bleeding time (HP:0003010) | 1.85915685 |
| 116 | Encephalitis (HP:0002383) | 1.85297269 |
| 117 | IgA deficiency (HP:0002720) | 1.84425321 |
| 118 | Arthralgia (HP:0002829) | 1.83074783 |
| 119 | Abnormality of complement system (HP:0005339) | 1.82394967 |
| 120 | Chest pain (HP:0100749) | 1.82363430 |
| 121 | Restrictive lung disease (HP:0002091) | 1.80448927 |
| 122 | Mitral stenosis (HP:0001718) | 1.80322675 |
| 123 | Vertebral compression fractures (HP:0002953) | 1.73959625 |
| 124 | Cheilitis (HP:0100825) | 1.72769464 |
| 125 | Poor head control (HP:0002421) | 1.72047853 |
| 126 | Thyroiditis (HP:0100646) | 1.71117755 |
| 127 | Pathologic fracture (HP:0002756) | 1.67730377 |
| 128 | Progressive visual loss (HP:0000529) | 1.66700877 |
| 129 | Loss of speech (HP:0002371) | 1.65518797 |
| 130 | Abnormal platelet volume (HP:0011876) | 1.64161021 |
| 131 | Agammaglobulinemia (HP:0004432) | 1.63256252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 5.15467284 |
| 2 | BLK | 4.89156238 |
| 3 | RIPK4 | 4.63716450 |
| 4 | MAP3K14 | 3.96559152 |
| 5 | TBK1 | 2.92261402 |
| 6 | TYK2 | 2.86274725 |
| 7 | MAP4K1 | 2.46150415 |
| 8 | EPHB1 | 2.35950039 |
| 9 | CSK | 2.32126131 |
| 10 | ERN1 | 2.26322021 |
| 11 | IRAK3 | 2.17522780 |
| 12 | MAP3K12 | 2.14477785 |
| 13 | BTK | 2.09945928 |
| 14 | IKBKE | 2.05738273 |
| 15 | ZAP70 | 1.94342728 |
| 16 | IKBKB | 1.93659453 |
| 17 | PBK | 1.84502596 |
| 18 | TXK | 1.80844764 |
| 19 | STK10 | 1.75177508 |
| 20 | FGR | 1.69538532 |
| 21 | HCK | 1.61609742 |
| 22 | TEC | 1.55600125 |
| 23 | MARK3 | 1.52236759 |
| 24 | KIT | 1.48154773 |
| 25 | JAK1 | 1.47339992 |
| 26 | PRPF4B | 1.43979949 |
| 27 | JAK3 | 1.42675156 |
| 28 | CLK1 | 1.37230609 |
| 29 | SYK | 1.36247975 |
| 30 | FES | 1.33546707 |
| 31 | MST4 | 1.28630508 |
| 32 | TRPM7 | 1.24376764 |
| 33 | MAP3K11 | 1.22519783 |
| 34 | LYN | 1.20823947 |
| 35 | RPS6KA4 | 1.16406339 |
| 36 | CHUK | 1.15947148 |
| 37 | JAK2 | 1.15029927 |
| 38 | MAP3K13 | 1.13774687 |
| 39 | TAOK2 | 1.09966844 |
| 40 | MAP2K3 | 1.08729373 |
| 41 | LRRK2 | 1.06550396 |
| 42 | NEK9 | 1.04955864 |
| 43 | CSF1R | 1.04264668 |
| 44 | GRK6 | 1.00141483 |
| 45 | TAOK3 | 0.99776579 |
| 46 | PRKG2 | 0.91292693 |
| 47 | ERBB3 | 0.90645051 |
| 48 | IRAK2 | 0.90579057 |
| 49 | LCK | 0.89511490 |
| 50 | PIM1 | 0.89438221 |
| 51 | ITK | 0.86407018 |
| 52 | TTN | 0.86243060 |
| 53 | ABL2 | 0.85004056 |
| 54 | KSR2 | 0.82027531 |
| 55 | DAPK2 | 0.81421745 |
| 56 | IRAK1 | 0.78925941 |
| 57 | CDC42BPA | 0.78824136 |
| 58 | PRKD2 | 0.78274054 |
| 59 | MARK2 | 0.78266008 |
| 60 | TGFBR2 | 0.78012455 |
| 61 | NME2 | 0.77258225 |
| 62 | RIPK1 | 0.76007911 |
| 63 | BMX | 0.75074735 |
| 64 | MAP2K6 | 0.74394971 |
| 65 | MAP3K6 | 0.72658511 |
| 66 | BMPR2 | 0.72502330 |
| 67 | MATK | 0.71206731 |
| 68 | YES1 | 0.70152523 |
| 69 | MAPKAPK2 | 0.65757270 |
| 70 | PTK6 | 0.65539137 |
| 71 | GRK7 | 0.61866231 |
| 72 | ACVR1B | 0.61173358 |
| 73 | MAP3K5 | 0.60910115 |
| 74 | EGFR | 0.58581120 |
| 75 | MAP2K4 | 0.58566602 |
| 76 | CAMKK2 | 0.58047369 |
| 77 | ABL1 | 0.57557476 |
| 78 | STK4 | 0.57079518 |
| 79 | PRKCD | 0.56803972 |
| 80 | KDR | 0.56457069 |
| 81 | PIM2 | 0.54248675 |
| 82 | FRK | 0.54039578 |
| 83 | STK11 | 0.52859454 |
| 84 | MAP3K2 | 0.52063441 |
| 85 | TRIB3 | 0.51783904 |
| 86 | EIF2AK2 | 0.51000990 |
| 87 | SIK3 | 0.50980588 |
| 88 | MAPK7 | 0.50959065 |
| 89 | EPHA3 | 0.50275932 |
| 90 | PAK4 | 0.49796595 |
| 91 | PRKCQ | 0.49272469 |
| 92 | FYN | 0.49155698 |
| 93 | CDK19 | 0.48379191 |
| 94 | ALK | 0.46324750 |
| 95 | HIPK2 | 0.44773016 |
| 96 | MAP3K1 | 0.44537586 |
| 97 | MAP3K7 | 0.43912609 |
| 98 | MAPK12 | 0.43892183 |
| 99 | RPS6KC1 | 0.42121308 |
| 100 | RPS6KL1 | 0.42121308 |
| 101 | DYRK1B | 0.41896983 |
| 102 | FGFR3 | 0.40793605 |
| 103 | KSR1 | 0.40367669 |
| 104 | MAP3K3 | 0.37597871 |
| 105 | SIK2 | 0.35911698 |
| 106 | MAP3K8 | 0.35405374 |
| 107 | TESK2 | 0.35259164 |
| 108 | NLK | 0.33447927 |
| 109 | DYRK3 | 0.32316375 |
| 110 | MAPK4 | 0.32311242 |
| 111 | PRKCZ | 0.30671236 |
| 112 | RPS6KA1 | 0.30474476 |
| 113 | GRK1 | 0.30462348 |
| 114 | PTK2B | 0.30315809 |
| 115 | PDK1 | 0.30046894 |
| 116 | STK38 | 0.29760466 |
| 117 | PRKAA2 | 0.29478483 |
| 118 | RAF1 | 0.28556730 |
| 119 | PDPK1 | 0.28364085 |
| 120 | SGK2 | 0.28344020 |
| 121 | PIK3CG | 0.24304239 |
| 122 | CDK12 | 0.23310188 |
| 123 | RPS6KA6 | 0.23105242 |
| 124 | MOS | 0.20167853 |
| 125 | PTK2 | 0.18328630 |
| 126 | ADRBK2 | 0.17496047 |
| 127 | TNK2 | 0.17090000 |
| 128 | SRC | 0.15003516 |
| 129 | SGK3 | 0.14801683 |
| 130 | TAOK1 | 0.14555674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.88032083 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.65151032 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.51575149 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.64231549 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.55095982 |
| 6 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.54495352 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.45721256 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.44789453 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.39606866 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.38779058 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.29745979 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.28571364 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.23001014 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.04095781 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.89868614 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.89602227 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.88687394 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.86769749 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.83225217 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.82751098 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.76848626 |
| 22 | Salmonella infection_Homo sapiens_hsa05132 | 1.73650824 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72639325 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.72512917 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70728243 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.70268550 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.65427435 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.64844144 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.63388972 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.58695539 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.56438115 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.48264319 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.45999053 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45193900 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.34757689 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34223974 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33931288 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.32574439 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30686919 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.28921528 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22930974 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21485437 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.21272483 |
| 44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08982424 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.08059808 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04789183 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.03748983 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.03341858 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97929540 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94968741 |
| 51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.89715372 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87900159 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.87754692 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.87211995 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.87034050 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81666978 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79077147 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74640024 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73178315 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72868787 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70236538 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66734905 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66000277 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63950977 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62599752 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59665974 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59384246 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56289145 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56206273 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54329147 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54115894 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51945825 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51511992 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50957393 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47381639 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43258735 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.43231419 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42211321 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.42115993 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40825147 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36873122 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.36810040 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.35221413 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34052835 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32373960 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31411317 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30915235 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30697205 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30094203 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29105851 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28608682 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27977261 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26376721 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25706470 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25286975 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23725255 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23269238 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22845978 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22814719 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | 0.22613976 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.22497519 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19913755 |
| 103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.18949637 |
| 104 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.16271860 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.15438552 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15105001 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13851736 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.11992513 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.11730897 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.10232058 |
| 111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.10012180 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.09639321 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.07917813 |

